Search results
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 6 hours agoIt lost $3.07 per share, flipping from a year-earlier gain of 19 cents. But that beat projections...
WHO COVID vaccine advisers recommend switch to JN.1 strain
Center for Infectious Disease Research and Policy· 3 days agoThe World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition, which...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 4 hours agoThe Spikevax story is over, but... Barring a renewed Covid surge -- fingers crossed! -- there isn't much future in Spikevax. Yet as ever, Moderna...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 10 hours agoIt is nice to see a company recognizing our IP and asking us for a license. Second, we recently announced a contract to provide 12.5 million doses of ...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 15 hours agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
COVID-19 hospitalizations hit record low, the CDC says
ABC News via Yahoo News· 2 days agoWeekly COVID-19 hospitalizations have hit their lowest level ever reported since the pandemic began,...
Supreme Court Rejects Military Chaplains' Lawsuit Claiming Refusal of COVID-19 Vaccine Hurt Their...
Military.com via Yahoo News· 2 days agoThe justices rejected a petition from 39 military chaplains who said they continue to face...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 11 hours agoManagement expects to record around $0.3 billion in product sales in first...expects capital...
University of Minnesota strengthens case to treat COVID-19 with metformin, not ivermectin
Tribune via AOL· 7 hours agoPatients with COVID-19 had lower viral loads if treated with metformin, according to new University of Minnesota research that argues for broader use of ...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 16 hours agoThe company reported a first-quarter net loss of $1.175 billion, or $3.07 a share, after net income...
